婴儿恶性百日咳:多中心队列研究中与死亡相关的因素
这项多中心队列研究回顾了2008年1月至2013年11月法国8个儿科ICU收治的23例恶性百日咳婴儿(<3月龄、呼吸窘迫、百日咳诊断、WBC≥50 G/l),比较存活与死亡患儿的临床和生物学特征,并回顾性评估治疗是否符合Rowlands算法。23例中9例(40%)死亡;死亡患儿更常出现心血管衰竭(100% vs 36%,p=0.003)和肺动脉高压(100% vs 29%,p=0.002),白细胞增长速度更快(中位数21.3 [9.7-28] G/l/天 vs 5.9 [3.0-6.8] G/l/天,p=0.007)。白细胞增长率>12 G/l/天和淋巴细胞/中性粒细胞比值<1与死亡显著相关(p=0.001和p=0.003)。遵循Rowlands策略与生存相关(100% vs 0%;p<0.001,死亡相对风险=0.18,95%CI [0.05-0.64])。作者认为应密切监测白细胞以早期识别死亡高危婴儿。
要点
- 23例恶性百日咳婴儿中9例(40%)死亡;死亡患儿心血管衰竭(100% vs 36%,p=0.003)和肺动脉高压(100% vs 29%,p=0.002)更常见。
- 死亡患儿白细胞增长速度更快:中位数21.3 [9.7-28] G/l/天 vs 存活患儿5.9 [3.0-6.8] G/l/天(p=0.007)。
- 白细胞增长率>12 G/l/天与死亡显著相关(p=0.001);淋巴细胞/中性粒细胞比值<1与死亡显著相关(p=0.003)。
- 10例(43%)接受白细胞去除,7例(30%)接受ECLS;遵循Rowlands策略与生存相关(100% vs 0%;p<0.001,死亡相对风险=0.18,95%CI [0.05-0.64])。
- 作者认为应密切监测白细胞,以早期识别恶性百日咳病程中死亡高危婴儿。
适用人群与场景
- 2008年1月至2013年11月法国8个儿科ICU收治的<3月龄婴儿,因呼吸窘迫入院、诊断为百日咳且WBC计数≥50 G/l(恶性百日咳)。
诊断标准与关键阈值
- 恶性百日咳定义(本研究纳入标准):<3月龄、呼吸窘迫、百日咳诊断、WBC≥50 G/l。
- 白细胞增长率>12 G/l/天与死亡显著相关(p=0.001);淋巴细胞/中性粒细胞比值<1与死亡显著相关(p=0.003)。
- 白细胞增长最佳阈值通过ROC曲线法获得。
处置流程与药物剂量
- 治疗管理(白细胞去除和/或ECLS)回顾性评估是否符合Rowlands算法(特定治疗的指征和时机)。
- 10例(43%)接受白细胞去除,7例(30%)接受ECLS。
- 遵循Rowlands策略与生存相关(100% vs 0%;p<0.001,死亡相对风险=0.18,95%CI [0.05-0.64])。
红旗征与不能漏的情况
- 心血管衰竭:死亡患儿100% vs 存活患儿36%(p=0.003)。
- 肺动脉高压:死亡患儿100% vs 存活患儿29%(p=0.002)。
- 白细胞快速增长:死亡患儿中位数21.3 [9.7-28] G/l/天 vs 存活患儿5.9 [3.0-6.8] G/l/天(p=0.007)。
研究设计与关键结果
- 研究类型:多中心队列研究(回顾性评估治疗符合性),8个法国儿科ICU,2008年1月至2013年11月,纳入23例恶性百日咳婴儿。
- 主要结果:9/23(40%)死亡;死亡患儿心血管衰竭(100% vs 36%,p=0.003)和肺动脉高压(100% vs 29%,p=0.002)更常见;白细胞增长中位数21.3 [9.7-28] G/l/天 vs 5.9 [3.0-6.8] G/l/天(p=0.007)。
- 白细胞增长率>12 G/l/天与死亡显著相关(p=0.001);淋巴细胞/中性粒细胞比值<1与死亡显著相关(p=0.003)。
- 10例(43%)接受白细胞去除,7例(30%)接受ECLS;遵循Rowlands策略与生存相关(100% vs 0%;p<0.001,死亡相对风险=0.18,95%CI [0.05-0.64])。
证据类型、等级与局限
- 证据类型:多中心队列研究(回顾性评估治疗符合性)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,这些发现应促使临床医生密切监测白细胞,以便在恶性百日咳病程中早期识别有致命结局风险的婴儿。
- 作者认为,在高死亡风险婴儿中这种早期信号将增加对Rowlands策略合规护理的可行性,并期望获得更好的生存。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Malignant pertussis (MP) affects young infants and is characterized by respiratory distress, perpetual tachycardia and hyperleukocytosis up to 50 G/l, leading to multiple organ failure and death in 75% of cases. Leukodepletion may improve prognosis. A therapeutic strategy based on leukodepletion and extracorporeal life support (ECLS) according to different thresholds of leucocytes has been proposed by Rowlands and colleagues. We aimed at identifying factors associated with death and assess whether the respect of the Rowlands' strategy is associated with survival.
METHODS: We reviewed all MP infants hospitalized in eight French pediatric intensive care units from January 2008 to November 2013. All infants younger than 3 months of age, admitted for respiratory distress with a diagnosis of pertussis and WBC count ≥ 50 G/l were recorded. Evolution of WBC was analyzed and an optimal threshold for WBC growth was obtained using the ROC-curve method. Clinical and biological characteristics of survivors and non-survivors were compared. Therapeutic management (leukodepletion and/or ECLS) was retrospectively assessed for compliance with Rowlands' algorithm (indication and timing of specific treatments).
RESULTS: Twenty-three infants were included. Nine of 23 (40%) died: they presented more frequently cardiovascular failure (100% vs 36%, p = 0.003) and pulmonary hypertension (PHT; 100% vs 29%, p = 0.002) than survivors and the median [IQR] WBC growth was significantly faster among them (21.3 [9.7-28] G/l/day vs 5.9 [3.0-6.8] G/l/day, p = 0.007). WBC growth rate > 12 G/l/day and lymphocyte/neutrophil ratio < 1 were significantly associated with death (p = 0.001 and p = 0.003, respectively). Ten infants (43%) underwent leukodepletion, and seven (30%) underwent ECLS. Management following Rowlands' strategy was associated with survival (100% vs 0%; p < 0.001, relative risk of death = 0.18, 95%-CI [0.05-0.64]).
CONCLUSIONS: A fast leukocyte growth and leukocytosis with neutrophil predominance during acute pertussis infection were associated with death. These findings should prompt clinicians to closely monitor white blood cells in order to early identify infants at risk of fatal outcome during the course of malignant pertussis. Such an early signal in infants at high risk of death would increase feasibility of compliant care to Rowlands' strategy, with the expectation of a better survival.
参考来源
- Coquaz-Garoudet M, Ploin D, Pouyau R, et al. Malignant pertussis in infants: factors associated with mortality in a multicenter cohort study. Ann Intensive Care. 2021. PMID: 33961197. doi:10.1186/s13613-021-00856-y
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。